- Megan Paquin

Choose the health content that’s right for you, and get it delivered right in your inbox.
The AdventHealth Neuroscience Institute is celebrating a new designation as one of only 20 ELITE GammaTile Centers in the U.S. This recognition comes as the institute’s neurosurgeons and oncologists have successfully completed 10 GammaTile procedures since becoming the first in Central Florida to treat aggressive brain tumors with this advanced technology.
GammaTile Therapy is a novel Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors. Implanted in the last five minutes of brain tumor removal surgery, each bioresorbable, 3D-collagen GammaTile is embedded with radiation sources. GammaTile Therapy delivers a sustained, controlled, therapeutic radiation dose, targeting tumor cells while sparing healthy tissue.

“Our commitment to complete, whole-person neurological care begins with our world-class specialists who consistently seek out leading-edge therapies for our patients,” said Craig Brubaker, vice president of AdventHealth’s Neuroscience Institute. “This milestone exemplifies their dedication, and we are pleased to be able to bring this advanced level of brain care to residents of this community.”
Dr. Melvin Field added, “This innovation is giving our patients a head-start in the fight against brain tumors. With GammaTile, we can immediately and precisely target cancer-involved tissues with a high dose of radiation, potentially extending our patients lives and helping maintain a higher quality of life throughout their treatment.”
In the past 50 years, only seven drugs or devices have been FDA-approved or -cleared to treat brain tumors. The latest advancement in brain tumor treatment, GammaTile Therapy was FDA-cleared in 2018 for recurrent brain tumors, including recurrent high-grade gliomas, glioblastomas, meningiomas and brain metastases. In 2020, the FDA expanded that indication to include newly diagnosed malignant brain tumors. For more information, visit the AdventHealth Neuroscience Institute’s brain tumor program here.
Recent News
Expected to open by 2026, the AdventHealth Training Center at Jackie Robinson Ballpark will enhance player wellness and support downtown revitalization.
AdventHealth and Orange County collaborate to enhance mortality and neurological outcomes at AdventHealth Orlando.
Nicol McGough understands all too well how physical inactivity brought on by illness or injury can severely damage a person’s well-being.
AdventHealth Primary Care Clinic is thrilled to announce the addition of Jessica Napier, PA-C, to our Women's Care Team. Jessica will be joining Dr. Shawn Gorden in providing comprehensive women's...
AdventHealth Heart of Florida and AdventHealth Lake Wales earn prestigious national recognition for promoting organ, eye and tissue donation
AdventHealth Wesley Chapel is proud to announce its groundbreaking achievement as the first hospital in Pasco County to perform a new, minimally invasive renal denervation (RDN) procedure.
AdventHealth South Overland Park has continued its commitment to infant and maternal health by earning recognition through High 5 for Mom & Baby, a program developed by the United Methodist Health...
The expansion of the AdventHealth Cancer Institute will bring world-class care close to home for residents of the West Orange and South Lake communities.
AdventHealth is proud to announce the addition of Dr. Christopher G. Yeary, D.O., FACOS, FACS, to our esteemed team of healthcare professionals. Dr. Yeary is a distinguished general surgeon with over...
AdventHealth's Bobby Nibhanupudy, MD, discusses the importance of organ donation and explains just how easy it is to sign up to become an organ donor.
To lower the risk of cancer, it's essential to adopt a healthy lifestyle. This includes not using tobacco products, maintaining a healthy weight, engaging in regular physical activity, eating a...
AdventHealth has developed a dashboard to help clinicians earlier identify the necessary practice changes to improve survival rates among sepsis patients.